Literature DB >> 27353278

Factors contributing to the development of overt encephalopathy in liver cirrhosis patients.

Motoh Iwasa1, Ryosuke Sugimoto2, Rumi Mifuji-Moroka2, Nagisa Hara3, Kyoko Yoshikawa2, Hideaki Tanaka2, Akiko Eguchi2, Norihiko Yamamoto2, Kazushi Sugimoto2, Yoshinao Kobayashi2, Hiroshi Hasegawa2, Yoshiyuki Takei2.   

Abstract

The aim of this study was to clarify the relationships among psychometric testing results, blood ammonia (NH3) levels, electrolyte abnormalities, and degree of inflammation, and their associations with the development of overt hepatic encephalopathy (HE) in liver cirrhosis (LC) patients. The relationships between covert HE and blood NH3, sodium (Na), and C-reactive protein (CRP) were examined in 40 LC patients. The effects of elevated NH3, hyponatremia, and elevated CRP on the development of overt HE were also investigated. The covert HE group had significantly lower serum Na levels and significantly higher serum CRP levels. During the median observation period of 11 months, 10 patients developed overt HE, and the results of multivariate analysis showed that covert HE and elevated blood NH3 were factors contributing to the development of overt HE. Electrolyte abnormalities and mild inflammation are involved in the pathogenesis of HE. Abnormal psychometric testing results and hyperammonemia are linked to subsequent development of overt HE.

Entities:  

Keywords:  Ammonia; Hepatic encephalopathy; Hyponatremia; Inflammation; Liver cirrhosis

Mesh:

Substances:

Year:  2016        PMID: 27353278     DOI: 10.1007/s11011-016-9862-6

Source DB:  PubMed          Journal:  Metab Brain Dis        ISSN: 0885-7490            Impact factor:   3.584


  24 in total

1.  Persistent ascites and low serum sodium identify patients with cirrhosis and low MELD scores who are at high risk for early death.

Authors:  Douglas M Heuman; Souheil G Abou-Assi; Adil Habib; Leslie M Williams; R Todd Stravitz; Arun J Sanyal; Robert A Fisher; Anastasios A Mihas
Journal:  Hepatology       Date:  2004-10       Impact factor: 17.425

Review 2.  Inflammation: A novel target of current therapies for hepatic encephalopathy in liver cirrhosis.

Authors:  Ming Luo; Jian-Yang Guo; Wu-Kui Cao
Journal:  World J Gastroenterol       Date:  2015-11-07       Impact factor: 5.742

3.  Value of the apparent diffusion coefficient for quantification of low-grade hepatic encephalopathy.

Authors:  Ryosuke Sugimoto; Motoh Iwasa; Masayuki Maeda; Naohito Urawa; Hideaki Tanaka; Naoki Fujita; Yoshinao Kobayashi; Kan Takeda; Masahiko Kaito; Yoshiyuki Takei
Journal:  Am J Gastroenterol       Date:  2008-05-28       Impact factor: 10.864

4.  Patients with hyponatremic cirrhosis have low-grade cerebral edema and poor quality-of-life.

Authors:  Motoh Iwasa; Ryosuke Sugimoto; Yoshiyuki Takei
Journal:  Ann Hepatol       Date:  2014 May-Jun       Impact factor: 2.400

5.  Factors related to quality of life in patients with cirrhosis and ascites: relevance of serum sodium concentration and leg edema.

Authors:  Elsa Solà; Hugh Watson; Isabel Graupera; Fanny Turón; Rogelio Barreto; Ezequiel Rodríguez; Marco Pavesi; Vicente Arroyo; Mónica Guevara; Pere Ginès
Journal:  J Hepatol       Date:  2012-07-20       Impact factor: 25.083

6.  Correction of hyponatraemia improves cognition, quality of life, and brain oedema in cirrhosis.

Authors:  Vishwadeep Ahluwalia; Douglas M Heuman; George Feldman; James B Wade; Leroy R Thacker; Edith Gavis; HoChong Gilles; Ariel Unser; Melanie B White; Jasmohan S Bajaj
Journal:  J Hepatol       Date:  2014-08-08       Impact factor: 25.083

7.  Probiotic VSL#3 reduces liver disease severity and hospitalization in patients with cirrhosis: a randomized, controlled trial.

Authors:  Radha K Dhiman; Baldev Rana; Swastik Agrawal; Ashish Garg; Madhu Chopra; Kiran K Thumburu; Amit Khattri; Samir Malhotra; Ajay Duseja; Yogesh K Chawla
Journal:  Gastroenterology       Date:  2014-08-27       Impact factor: 22.682

8.  Magnetic resonance quantification of water and metabolites in the brain of cirrhotics following induced hyperammonaemia.

Authors:  Hanan Mardini; Fiona E Smith; Christopher O Record; Andrew M Blamire
Journal:  J Hepatol       Date:  2011-02-03       Impact factor: 25.083

9.  Development of quantitative neuropsychological tests for diagnosis of subclinical hepatic encephalopathy in liver cirrhosis patients and establishment of diagnostic criteria-multicenter collaborative study in Japanese.

Authors:  Akinobu Kato; Motoichiro Kato; Hiromasa Ishii; Yosuke Ichimiya; Kazuyuki Suzuki; Hironaka Kawasaki; Shin-Ichiro Yamamoto; Ryukichi Kumashiro; Kyosuke Yamamoto; Naohiro Kawamura; Naoaki Hayashi; Shohei Matsuzaki; Akira Terano; Kiwamu Okita; Akiharu Watanabe
Journal:  Hepatol Res       Date:  2004-10       Impact factor: 4.288

Review 10.  Pathophysiology and management of hepatic encephalopathy 2014 update: Ammonia toxicity and hyponatremia.

Authors:  Motoh Iwasa; Yoshiyuki Takei
Journal:  Hepatol Res       Date:  2015-03-02       Impact factor: 4.288

View more
  6 in total

Review 1.  Water, electrolyte, acid-base, and trace elements alterations in cirrhotic patients.

Authors:  Carlos G Musso; Rossina Juarez; Richard J Glassock
Journal:  Int Urol Nephrol       Date:  2017-06-12       Impact factor: 2.370

2.  Efficacy of rifaximin against covert hepatic encephalopathy and hyperammonemia in Japanese patients.

Authors:  Masato Nakai; Goki Suda; Koji Ogawa; Sonoe Yoshida; Shunichi Hosoda; Akinori Kubo; Yoshimasa Tokuchi; Takashi Kitagataya; Ren Yamada; Taku Shigesawa; Masatsugu Ohara; Takuya Sho; Kenichi Morikawa; Naoya Sakamoto
Journal:  PLoS One       Date:  2022-07-01       Impact factor: 3.752

3.  Hyperammonemia Is Associated with Increasing Severity of Both Liver Cirrhosis and Hepatic Encephalopathy.

Authors:  Abidullah Khan; Maimoona Ayub; Wazir Mohammad Khan
Journal:  Int J Hepatol       Date:  2016-10-25

4.  Chinese guidelines on management of hepatic encephalopathy in cirrhosis.

Authors:  Xiao-Yuan Xu; Hui-Guo Ding; Wen-Gang Li; Ji-Dong Jia; Lai Wei; Zhong-Ping Duan; Yu-Lan Liu; En-Qiang Ling-Hu; Hui Zhuang; Chinese Society Of Hepatology; Chinese Medical Association
Journal:  World J Gastroenterol       Date:  2019-09-28       Impact factor: 5.742

5.  Prediction of minimal hepatic encephalopathy by using an radiomics nomogram in chronic hepatic schistosomiasis patients.

Authors:  Ying Li; Shuai Ju; Xin Li; Yan Li Zhou; Jin Wei Qiang
Journal:  PLoS Negl Trop Dis       Date:  2021-10-15

6.  Natural history of covert hepatic encephalopathy: An observational study of 366 cirrhotic patients.

Authors:  An-Jiang Wang; A-Ping Peng; Bi-Min Li; Na Gan; Li Pei; Xue-Lian Zheng; Jun-Bo Hong; Hai-Ying Xiao; Jia-Wei Zhong; Xuan Zhu
Journal:  World J Gastroenterol       Date:  2017-09-14       Impact factor: 5.742

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.